ACH

ACCENDRA HEALTH INC/VA/ ACH

NYSESmall CapHealthcare

13F Pro quality score

Rank #2,483 of 2,925

Why it scores 30Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$613.23M

Quarter to Jun 30

Net income

$-89.07M

Quarter to Jun 30

Free cash flow

$-73.59M

Quarter to Jun 30

Operating margin

-5.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$213.19M total
Coliseum Capital Management, LLC
$44.80M0.0%
BlackRock, Inc.
$18.82M+5.1%
BANK OF AMERICA CORP /DE/
$12.91M+10.8%
VANGUARD CAPITAL MANAGEMENT LLC
$10.56M-5.9%
D. E. Shaw & Co., Inc.
$10.54M-7.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$9.88M-20.6%
Invenomic Capital Management LP
$9.62M-16.5%
MARSHALL WACE, LLP
$8.83M+46.7%
PARADIGM CAPITAL MANAGEMENT INC/NY
$8.68M+42.0%
VANGUARD PORTFOLIO MANAGEMENT LLC
$6.95M-23.4%
Dana Investment Advisors, Inc.
$6.65M+30.9%
GEODE CAPITAL MANAGEMENT, LLC
$6.41M+2.0%
DIMENSIONAL FUND ADVISORS LP
$5.61M-37.1%
STATE STREET CORP
$5.48M-1.8%
Connor, Clark & Lunn Investment Management Ltd.
$4.41M-6.7%
AQR CAPITAL MANAGEMENT LLC
$3.65M+45.8%
GOLDMAN SACHS GROUP INC
$2.92M-9.2%
ACADIAN ASSET MANAGEMENT LLC
$2.80M-9.6%
TWO SIGMA INVESTMENTS, LP
$2.46M-40.2%
NORTHERN TRUST CORP
$1.99M-3.2%
WOLVERINE ASSET MANAGEMENT LLC
$1.94M-18.3%
TUDOR INVESTMENT CORP ET AL
$1.94M+163.2%
Vanguard Global Advisers, LLC
$1.74M+20.5%
VANGUARD FIDUCIARY TRUST CO
$1.67M+4.1%
BW Gestao de Investimentos Ltda.
$1.45MNew
See all 140 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ACH

Earnings Per Share

13fpro.ai/company/ACH

Loading ratio trend…

ACH key financials by period

Reported revenue, net income and operating margin by fiscal year, from ACCENDRA HEALTH INC/VA/'s annual filings on SEC EDGAR.

ACCENDRA HEALTH INC/VA/ reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$2.8B$-1.1B1.0%
FY 2024$2.7B$-362.7M-8.1%
FY 2023$2.6B$-41.3M5.2%
FY 2022$10.0B$22.4M1.4%
FY 2021$9.8B$221.6M3.8%
FY 2020$8.5B$29.9M2.4%
Source: ACH filings on SEC EDGAR →

Companies similar to ACH

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

ACH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ACCENDRA HEALTH INC/VA/ (ACH): stock profile, AI score and financials

ACCENDRA HEALTH INC/VA/ (ACH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACH at 29.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,483 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (1.0) and free cash flow (15.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), ACCENDRA HEALTH INC/VA/ reports quarterly revenue of $613.2M, net income of $-89.1M, an operating margin of -5.7%. Top institutional holders of ACH by reported 13-F value include Coliseum Capital Management, BlackRock, BANK OF AMERICA, based on the most recent SEC filings. ACH trades on the NYSE exchange and files with the SEC under CIK 75252. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACCENDRA HEALTH INC/VA/ directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 75252 →